Peptide Companion
Back to catalog
Peptide Companion
single
Healing & Recovery
Vial: 10 mg

BPC-157 (10 mg Vial)

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide derived from a gastric protein sequence studied for tissue-healing and cytoprotective properties. Preclinical models demonstrate accelerated wound repair and anti-inflammatory activity, though human clinical data remain limited to early-phase safety trials and small case reports. This educational protocol presents a once-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.

Dose
0.25–0.5 mg per injection
Frequency
Once or twice daily
Timing
Morning and/or evening
Duration
4–8 weeks

Systemic healing effects. Can be injected near injury site or subcutaneously. Promotes angiogenesis.

Dosing Schedule
WeekDaily Dose (mcg)Units (per injection) (mL)
Weeks 1–2200 mcg (0.2 mg)6 units (0.06 mL)
Weeks 3–4400 mcg (0.4 mg)12 units (0.12 mL)
Weeks 5–8+600 mcg (0.6 mg)18 units (0.18 mL)
Supplies Needed
  • •Peptide Vials (BPC-157, 10 mg each):
  • •Insulin Syringes (U-100):
  • •Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution.
  • •Alcohol Swabs: One for the vial stopper + one for the injection site each day.
References

  • Journal of Pharmacological Sciences

    Klicek R et al. BPC-157 promotes colocutaneous fistula healing via NO-system modulation (rat model)

    View source

  • Pharmaceuticals (MDPI)

    Józwiak M et al. Multifunctionality and possible medical application of BPC-157: literature and patent review (2025)

    View source

  • Current Pharmaceutical Design (PMC)

    Sikiric P et al. BPC-157 stable gastric pentadecapeptide: novel therapy for wound healing and tissue repair

    View source

  • Life Sciences

    Seiwerth S et al. BPC-157 and standard angiogenic growth factors: gastrointestinal tract healing and beyond

    View source

  • HSS Journal (PubMed)

    Vasireddi N et al. Emerging use of BPC-157 in orthopaedic sports medicine: systematic review (2025)

    View source

  • Journal of Orthopaedic Research

    Chang CH et al. BPC-157 promotes tendon-to-bone healing in a rat rotator cuff model

    View source

  • WHO (NCBI Bookshelf)

    Guideline on safety-engineered syringes for IM, ID, and SC injections in health care settings (2016)

    View source

  • Johns Hopkins Arthritis Center

    How to give a subcutaneous injection (patient education resource)

    View source

  • ClinicalTrials.gov

    NCT02637284: PCO-02 Phase I safety and pharmacokinetics trial of oral BPC-157

    View source

  • CDC

    Vaccine administration: subcutaneous route (angle/site; no aspiration)

    View source

  • Subcutaneous Drug Injection Review (PMC)

    Pharmacologic considerations of the subcutaneous route

    View source

  • World Journal of Gastroenterology (PMC)

    Sikiric P et al. Pentadecapeptide BPC-157: from GI tract to whole body healing

    View source

Educational content adapted from peptidedosages.com. Not medical advice.